Synergistic Neuromodulation Systems

A novel approach to neuromodulation therapy that integrates distinct technologies such as AI, IoT, blockchain, and new materials to create personalized stimulation targets, enhancing treatment outcomes and patient care.

Current neuromodulation therapies, such as TMS and DBS, often lack precision and effectiveness due to limited understanding of individual brain function. The original patent addressed this issue by generating personalized stimulation targets. However, the new inventive concept takes this a step further by combining the original patent's technology with advanced technologies to create a more powerful and efficient system.

The synergistic neuromodulation system comprises a neural network trained on a patient's brain data, a blockchain-based secure data storage system, an AI-powered recommendation engine, an IoT-enabled wearable device, and a new material-based implantable electrostimulator. The neural network directs the processor to obtain patient brain data, which is stored securely using the blockchain-based system. The AI-powered recommendation engine provides personalized stimulation targets, and the IoT-enabled wearable device delivers the brain stimulation therapy. The new material-based implantable electrostimulator enhances the therapy's effectiveness. The system optimizes treatment outcomes by integrating the patient's brain data with the database of brain stimulation therapy outcomes.

The new claims introduce the integration of AI, IoT, blockchain, and new materials into the original patent's technology, creating a synergistic system that enhances treatment outcomes and patient care. This integration is novel and non-obvious compared to the original patent.

Alternative embodiments could include using different AI algorithms or machine learning models, integrating with other wearable devices or implantable electrostimulators, or utilizing alternative blockchain-based secure data storage systems. Variations could also include using the system for different mental conditions or expanding the system to include other therapies.

The synergistic neuromodulation system has significant commercial potential in the healthcare industry, particularly in the fields of mental health and neuroscience. The system's ability to provide personalized and effective treatment outcomes could revolutionize the way neuromodulation therapies are delivered, making it an attractive solution for hospitals, clinics, and medical research institutions.